Lucas Kawa | Jan. 4, 2013, 6:22 PM |
Read more: http://www.businessinsider.com/goldman-sachs-40-stocks-with-upside-2013-1?op=1#ixzz2OsOX1l7b
Goldman Sachs’ equity strategy team released a list of stocks with the most upside given Goldman analysts’ price targets. The 40 stocks on the list offer 24% to 44% upside.
The list offers a large number of energy companies, which isn’t surprising given the fact that investors are looking to get in on America’s move toward energy independence.
Here, we’ve pulled five health-related stocks for your consideration.
(Stocks listed in alphabetical order)
Current Price: $96.80
Upside to target: 28%
A pharmaceutical company looking to develop cures for severe, life-threatening and rare diseases.
Current Price: $91.79
Upside to target: 24.2%
The company designs, manufactures and markets tissue heart valves and hemodynamic monitoring devices.
Current Price: $33.08
Upside to target: 26%
A leader in human and environmental health, offering therapeutic and disease research, prenatal screening, environmental testing and industrial monitoring.
Current Price: $56.15
Upside to target: 36.9%
A financial services and insurance firm offering life insurance and long-term care insurance.
Current Price: $56.65
Upside to target: 24%
A medical device and equipment manufacturer specializing in orthopedic medical technology.
Read the full list here